While older patients with HIV had a higher risk for cutaneous malignancies than younger adults with HIV, both groups had significantly higher risks for oncovirus infections when compared with ...

The study by Sari Reisner and colleagues1 in The Lancet HIV on gender-affirming hormone therapy and its effect on HIV ...

2024 — Researchers have shown that they can generate a strong immune response against HIV with two doses of a vaccine given one week ... Targeted Immune Intervention and Stopping ART in Model of ...

As of the end of 2023, nearly 40 million people worldwide were living with HIV, including approximately 1.2 million in the ...

Physicians and their patients report that engagement in an HIV-based community rivals drug effectiveness in the ongoing efforts to curtail an epidemic. Confronting the HIV Epidemic: There's an App ...

The phase 2a trial of AbiVax’s ABX464 pill is small but confirms the results seen in a previous trial: the drug reduced the viral reservoir in blood in patients with HIV. ABX464 is the company's ...

Aarav Vijai, 16, merges art & tech to empower children. Founder of Kensho Foundation, he drives change through ...

As the world marked World TB Day on Monday, Kenyan health advocates for people living with HIV and TB criticised the High Court for failing to hold the government accountable for HIV and TB drugs ...

Gilead has grown to become a leader in the fight against HIV and has announced efforts ... agreed to pay $40 million to approximately 2,600 patients who developed kidney and bone disease while ...

If left untreated, human immunodeficiency virus (HIV) almost always will progress to AIDS, even after many years. The immune defenses become compromised and the body is less able to defend itself ...

Haystack at Giverny, Poplars at the Water’s Edge, Morning on the Seine. These painting titles bring only one name to mind – ...